Literature DB >> 812886

Application of the single radial diffusion test for assay of antibody to influenza type A viruses.

S R Mostow, G C Schild, W R Dowdle, R J Wood.   

Abstract

Single radial diffusion (SRD) tests for antibodies to influenza type A hemagglutinin, neuraminidase, nucleoprotein, and matrix protein antigens were compared with conventional hemagglutination inhibition, neuraminidase inhibition, and complement fixation tests. Sera used in this study were obtained in 1968-1969 from volunteers before and after vaccination and before and after an ensuing epidemic of Hong Kong influenza. The SRD test compared favorably with conventional tests for assessment of vaccine- or infection-induced rises in antibody titers to influenza type A viruses. Little linear relationshiip was seen between zone areas with SRD and titers with conventional tests, suggesting that the SRD test may detect antibody of different quality or specificity. The SRD seemed equal to the hemagglutination inhibition test for predicting susceptibility to influenza. SRD is a simple test for the recognition of antibody to various antigenic components of the influenza virus and could prove to be a valuable epidemiological tool.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 812886      PMCID: PMC275217          DOI: 10.1128/jcm.2.6.531-540.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  CHARACTERIZATION OF "SOLUBLE" ANTIGENS DERIVED FROM CELLS INFECTED WITH SENDAI AND NEWCASTLE DISEASE VIRUSES.

Authors:  R ROTT; A P WATERSON; I M REDA
Journal:  Virology       Date:  1963-12       Impact factor: 3.616

2.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

3.  Future influenza vaccines and the use of genetic recombinants.

Authors:  E D Kilbourne
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  A quantitative, single-radial-diffusion test for immunological studies with influenza virus.

Authors:  G C Schild; M Henry-Aymard; H G Pereira
Journal:  J Gen Virol       Date:  1972-08       Impact factor: 3.891

5.  The polypeptide composition of influenza A viruses.

Authors:  J J Skehel; G C Schild
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

6.  Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus.

Authors:  J L Schulman; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

7.  A uronic and sialic acid free chick allantoic mucopolysaccharide sulphate which combines with influenza virus hi-antibody to host material. 1. Purification of the substance.

Authors:  G Haukenes; A Harboe; K Mortensson-Egnund
Journal:  Acta Pathol Microbiol Scand       Date:  1965

8.  Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

9.  Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy.

Authors:  S C Schoenbaum; S R Mostow; W R Dowdle; M T Coleman; H S Kaye
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

  9 in total
  10 in total

1.  Use of the enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study.

Authors:  R Jennings; T Smith; C W Potter
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

2.  Detection of antibodies to influenza virus M protein by an enzyme-linked immunosorbent assay.

Authors:  M W Khan; D J Bucher; A K Koul; G Kalish; H Smith; E D Kilbourne
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

3.  Formation of antibody to matrix protein in experimental human influenza A virus infections.

Authors:  L Cretescu; A S Beare; G C Schild
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

4.  The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.

Authors:  J S Oxford; G C Schild; C W Potter; R Jennings
Journal:  J Hyg (Lond)       Date:  1979-02

5.  Evaluation of the single radial hemolysis test for measuring hemagglutinin- and neuraminidase-specific antibodies to H3N2 influenza strains and antibodies to influenza B.

Authors:  K Farrohi; F K Farrohi; G R Noble; H S Kaye; A P Kendal
Journal:  J Clin Microbiol       Date:  1977-03       Impact factor: 5.948

6.  Matrix protein from influenza A virus and its role in cross-protection in mice.

Authors:  R G Webster; V S Hinshaw
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

7.  Anti M-protein antibody response to type A or B natural influenza detected by solid phase enzyme linked immunosorbent assay and by complement fixation.

Authors:  L Joassin; M Reginster; D Vaira
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

8.  The influenza virus: Antigenic composition and immune response.

Authors:  G C Schild
Journal:  Postgrad Med J       Date:  1979-02       Impact factor: 2.401

Review 9.  Purified viral neuraminidase vaccine to control influenza.

Authors:  D J Arora
Journal:  Can Med Assoc J       Date:  1979-12-22       Impact factor: 8.262

10.  Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza.

Authors:  Galina M Vodeiko; Jerry P Weir
Journal:  Influenza Other Respir Viruses       Date:  2011-09-08       Impact factor: 4.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.